read the full 2012 Annual Report - Colon Cancer Alliance
read the full 2012 Annual Report - Colon Cancer Alliance
read the full 2012 Annual Report - Colon Cancer Alliance
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3,200+<br />
Members<br />
100+<br />
daily users<br />
9<br />
Moderators<br />
24/7<br />
online<br />
Chat Room<br />
30 <strong>Colon</strong> <strong>Cancer</strong> <strong>Alliance</strong> <strong>2012</strong> <strong>Annual</strong> <strong>Report</strong><br />
My CCA SuppOrT ONLINE COMMuNITy<br />
Formerly My CRC Connections, <strong>the</strong> My CCA Support online Community celebrated<br />
its fifth year in <strong>2012</strong> with a new look, expanded resources and more members than ever.<br />
My CCA Support empowers those affected by colon cancer to find and communicate<br />
with one ano<strong>the</strong>r easily and conveniently.<br />
PATIENTS, SURVIVORS AND CAREGIVERS FROM AROUND<br />
THE WORLD CAN<br />
• Seek practical advice from peers who share a similar diagnosis<br />
• Provide and receive peer support through real-time chats in both English and Spanish<br />
• Share personal stories and experiences<br />
• Be part of a community of peers<br />
• Find support and comfort<br />
• Search for o<strong>the</strong>r members by diagnosis, stage and location<br />
3500<br />
My CCA Support members can participate in live chats, webinars<br />
and message boards, and can create personal pages with photos, 3000<br />
videos and blogs. New features include Volunteer Spotlights,<br />
information pages in Spanish, resource and education pages.<br />
2500<br />
To join or learn more, simply visit<br />
www.MyCCASupport.org.<br />
2000<br />
1500<br />
1000<br />
500<br />
0<br />
934<br />
MeMBeR GRoWtH<br />
1,601<br />
2,009<br />
2,550<br />
3,200<br />
2008 2009 2010 2011 <strong>2012</strong><br />
<strong>the</strong> My CCA Support online Community is sponsored by Bristol-Myers Squibb, Salix pharmaceuticals and Amgen.
Change language